HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy

Through whole-transcriptome profiling of HER2+ breast carcinomas (BCs), we previously showed that those sensitive to trastuzumab are addicted to this oncoprotein and are enriched in immune pathways, raising the hypothesis that HER2 itself regulates immune cell recruitment. In the present study we in...

Descripción completa

Detalles Bibliográficos
Autores principales: Triulzi, Tiziana, Forte, Luca, Regondi, Viola, Di Modica, Martina, Ghirelli, Cristina, Carcangiu, Maria Luisa, Sfondrini, Lucia, Balsari, Andrea, Tagliabue, Elda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287794/
https://www.ncbi.nlm.nih.gov/pubmed/30546951
http://dx.doi.org/10.1080/2162402X.2018.1512942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287794/
https://www.ncbi.nlm.nih.gov/pubmed/30546951
http://dx.doi.org/10.1080/2162402X.2018.1512942

Ejemplares similares